Chiropractors in Northern Mariana Islands - Medicare Status, Address, Contact
1 Chiropractors found. Showing 1 - 1
 Dr. Jonathan Ruben Goins, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 394 Nauru Loop St., Suite 204, Susupe, MP 96950 Phone: 670-989-4561 |
News Archive
William D. Carey Award for Boston University School of Medicine professor
Francis A. Farraye, MD, MSc, FACG, FASGE, a professor of medicine at Boston University School of Medicine (BUSM) and clinical director in the Gastroenterology Section at Boston Medical Center (BMC) recently received the William D. Carey Award from the American College of Gastroenterology (ACG). The award is reserved for an exceptional individual who has served the Board and the College with distinction.
NGS mutational testing can help detect patients with Barrett's esophagus
Barrett's esophagus (BE) develops in a subset of patients with gastroesophageal reflux disease (GERD) and can increase the risk of developing cancer of the esophagus. Although periodic surveillance for cancer is recommended for BE patients, these examinations may fail to identify pre-cancerous dysplasia and early cancers.
New role for the blood protein serum amyloid P in the body's response to medical materials
Using a technique called proteomics, the researchers identified many of the blood proteins that stick (adsorb) to the surfaces of medical devices. Blood proteins that adsorb to the surfaces of materials unfold and can be recognized by the body, which then mounts a response against the device.
New malaria initiative
According to the UN chief envoy for malaria a $5 billion campaign has saved several hundred thousand lives in recent years, keeping international efforts on track to virtually end deaths from the mosquito-borne disease by 2015. The UN reveals that about 780,000 people, mostly babies and toddlers in sub-Saharan Africa, now die from malaria annually, down from nearly 1 million in 2008.
Vertex reports superior SVR rates with telaprevir-based combination therapy in Phase 3 studies for hepatitis C
Vertex Pharmaceuticals Incorporated today announced new data from its Phase 3 studies of people with genotype 1 chronic hepatitis C who have not been treated previously. In these studies, the majority of people achieved superior sustained viral response (SVR or viral cure) rates with a telaprevir-based combination regimen, compared to current therapies, regardless of race/ethnicity or stage of liver fibrosis (factors known to limit response to current hepatitis C treatments).
› Verified 3 days ago